Proteome Sciences plc (LON:PRM – Get Free Report) shares reached a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.50 ($0.03), with a volume of 289750 shares traded. The stock had previously closed at GBX 2.76 ($0.04).
Proteome Sciences Stock Down 9.4 %
The firm’s 50 day simple moving average is GBX 3 and its 200-day simple moving average is GBX 3.38. The company has a market capitalization of £7.38 million, a PE ratio of -250.00 and a beta of 0.07.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Read More
- Five stocks we like better than Proteome Sciences
- Insider Trading – What You Need to Know
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Top Biotech Stocks: Exploring Innovation Opportunities
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- How to Use the MarketBeat Stock Screener
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.